Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Wuhan Hiteck Biological

PUBLIC STATUS
301-400 EMPLOYEES
300683 STOCK SYMBOL
$7.31 SHARE PRICE (As of Tuesday Closing)
Description

Developer of biological pharmaceutical products. The company's business is focused on nerve related drugs, thrombin and other chemicals research and development, production and sales through imported protein chromatography separation system, high-speed centrifuge, high-speed washing and drying production line, large-scale pharmaceutical vacuum freeze dryer, high-speed capping machine, laser Pen Maji, fermentation tank, high pressure homogenizer, , High-performance liquid chromatography system, gas chromatography system, high-speed refrigerated centrifuge, carbon dioxide shaker, pre-filling syringe vacuum filling machine, constant temperature and humidity box production, research and development and testing equipment.

Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Stock Exchange
SHE
Primary Office
  • Hite Science and Technology Park
  • Wuhan Economic Development Zone
  • Wuhan, Hubei 430056
  • China

+86 027 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Wuhan Hiteck Biological’s full profile, request a free trial.

Wuhan Hiteck Biological Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$6.54 - $10.92 $755M $7.31 $0.22 234K 103M

Wuhan Hiteck Biological Financials Summary

In Thousands,
USD
TTM
31-Mar-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 806,461 757,981
Revenue 107,487 111,019 115,747 108,190
EBITDA 23,762 24,612 27,665 16,285
Net Income 20,413 21,070 23,579 13,272
Total Assets 302,656 292,364 149,662 134,399
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Wuhan Hiteck Biological Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Wuhan Hiteck Biological‘s full profile, request access.

Request full access to PitchBook